city New Delhi Usa India covid-19 vaccine city New Delhi Usa India

J&J applies with DCGI to conduct bridging study for Janssen covid jab in India

Reading now: 974
www.livemint.com

NEW DELHI : Johnson & Johnson said on Tuesday that it has applied with the Drugs Controller General of India (DCGI) V.G.

Somani for an approval to conduct a local bridging study of the company's single-dose Janssen covid-19 vaccine in the country.A spokesperson for the company said, the study was aimed to comply with local regulations and added that the application was in line with its commitment to provide safety and efficacy data necessary to support worldwide emergency use of the Janssen covid-19 vaccine candidate.However, the American company has as of now not applied seeking emergency authorization for import of its vaccine under revised regulations which expedited licensing to foreign covid-19 vaccine manufacturers that have an.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA